- Home
- HOLX
HOLX
Hologic Inc.
as 05-08-2025 4:00pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 16.3B | IPO Year: | 1990 |
| Target Price: | $79.00 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.39 | EPS Growth: | 25.36 |
| 52 Week Low/High: | $51.90 - $84.67 | Next Earning Date: | 05-01-2025 |
| Revenue: | $4,026,500,000 | Revenue Growth: | 1.66% |
| Revenue Growth (this year): | 3.34% | Revenue Growth (next year): | 5.43% |
Latest Hologic Inc. News
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
StockStory
3 days ago
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 to Think Twice About
MT Newswires
4 days ago
Morgan Stanley Cuts Price Target on Hologic to $65 From $77, Keeps Equalweight Rating
Simply Wall St.
6 days ago
Hologic Second Quarter 2025 Earnings: EPS Misses Expectations
Morningstar Research
6 days ago
Analyst Report: Hologic, Inc.
MT Newswires
7 days ago
Citigroup Adjusts Hologic Price Target to $60 From $70
MT Newswires
7 days ago
Leerink Partners Adjusts Hologic Price Target to $60 From $65
MT Newswires
7 days ago
Jefferies Adjusts Hologic Price Target to $65 From $78
Compare HOLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.